|
|
|
40
|
1131FK
|
ATORVASTATIN 10MG TAB (UME/AHI)
|
ATORVASTATIN
|
ATORVASTATIN
|
3X10
|
A
|
1.44
|
0.05
|
TABLET
|
30
|
TAB
|
UME
|
UMEDICA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
1132GU
|
ATORVASTATIN 20MG TAB (UME/AHI)
|
ATORVASTATIN
|
ATORVASTATIN
|
3X10
|
A
|
4.65
|
0.16
|
TABLET
|
30
|
TAB
|
UME
|
UMEDICA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2022-10-19
|
Delete from contract
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
2022-09-07
|
|
|
|
40
|
1132GU
|
ATORVASTATIN 20MG TAB (UME/AHI)
|
ATORVASTATIN
|
ATORVASTATIN
|
3X10
|
A
|
1.74
|
0.058
|
TABLET IMMED
|
30
|
TAB
|
UME
|
UMEDICA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2023-03-20
|
2024-03-31
|
Add to Contract as Cat A
|
Oral
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
2023-01-12
|
|
|
|
40
|
1133FP
|
ATORVASTATIN 40MG TAB (UME/AHI)
|
ATORVASTATIN
|
ATORVASTATIN
|
3X10
|
A
|
2.53
|
0.08
|
TABLET
|
60
|
TAB
|
UME
|
UMEDICA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
7726BS
|
PIPERACILLIN | TAZOBACTAM 4G | 0.5G INJ (UME/AHI)
|
PIPERACILLIN|TAZOBACTAM
|
PIPERACILLIN|TAZOBACTAM
|
4.5G VIAL
|
BQ
|
4.46
|
4.46
|
INJECTION
|
0
|
VIAL
|
UME
|
UMEDICA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081216
|
PENICILLINS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-03-29
|